id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-P-0216-0003,FDA,FDA-2001-P-0216,FDA/CDER to Pharmacia Consumer Healthcare I,Other,PAV-Petition Approval,2002-05-16T04:00:00Z,2002,5,,,2008-04-25T02:38:56Z,,0,0,09000064804e4a2a
FDA-2001-P-0216-0002,FDA,FDA-2001-P-0216,"FDA/CDER to Paul, Hastings, Janofsky & Walker LLP",Other,LET-Letter,2001-09-11T04:00:00Z,2001,9,,,2008-04-25T02:38:56Z,,0,0,09000064804e4a25
FDA-2001-P-0216-0001,FDA,FDA-2001-P-0216,"FDA/DDM to Paul, Hastings, Janofsky & Walker LLP",Other,ACK-Acknowledgement Letter,2001-03-08T05:00:00Z,2001,3,,,2008-04-25T02:38:56Z,,0,0,09000064804e4970